Author： Vitaliti Giovanna Pavone Piero Guglielmo Francesco Falsaperla Raffaele
Publisher： Informa Healthcare
ISSN： 1744-666X
Source： Expert Review of Clinical Immunology, Vol.9, Iss.4, 2013-04, pp. : 385-390
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Allergen immunotherapy is a subject widely debated by allergists. Currently, there are controversial discussions focused on the sublingual route. Sublingual immunotherapy (SLIT) has so far been used in Europe, Asia and Australia for the treatment of allergic respiratory diseases. The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years of age. Nevertheless, it is known that SLIT efficacy is higher when SLIT is started at an earlier age. The aim of this review is to focus on studies in preschool children evaluating SLIT safety and efficacy, in order to improve this practice at an earlier age in childhood.
Related content
Sublingual immunotherapy in children with allergic polysensitization
By Ciprandi Giorgio Cadario Geovanni Di Gioacchino Giuseppe M. Gangemi Salvatore Gasparini Alberto Isola S. Marengo Fulvia Minelli Salvatore Ricciardi Leopoldo Ridolo Erminia Pravettoni Valerio Valle Carla Verini Marcello Zambito Marcello Incorvaia Cristoforo Puccinelli Paola Scurati Silvia Frati Franco Simonetta Masieri
Allergy and Asthma Proceedings, Vol. 31, Iss. 3, 2010-05 ,pp. :
Access to resources
Recommend
